Use of methadone and buprenorphine increased during delivery hospitalizations over a 9-year period, while receipt of other long-acting opioids decreased, a recent study found. Researchers analyzed the Perspective database to evaluate patterns of long-acting opioid use during delivery hospitalizations from January 2006 through March 2015. Medications evaluated included methadone, formulations including buprenorphine, and extended-release formulations of oxycodone, morphine, fentanyl, and other opioids. Among the findings:
- The analysis included 2,994,630 delivery hospitalizations.
- Use of long-acting opioids increased significantly during the study period from 457 to 844 per 100,000 deliveries.
- Although buprenorphine and methadone use increased, use of other long-acting opioids decreased.
- Risk for severe morbidity was significantly lower with buprenorphine or methadone compared with other long-acting opioids.
Duffy CR, Wright JD, Landau R, et al. Trends and outcomes associated with using long-acting opioids during delivery hospitalizations. [Published online ahead of print September 7, 2018]. Obstet Gynecol. doi:10.1097/AOG.0000000000002861.
This Week's Must Reads
Must Reads in Obstetrics
Term Cesarean Delivery & Subsequent Preterm Delivery, Am J Obstet Gynecol; ePub 2019 Feb 22; Vahanian, et al